University Clinical Hospital Mostar
About University Clinical Hospital Mostar
University Clinical Hospital Mostar is the largest hospital in Mostar, Bosnia and Herzegovina. It is situated in the Bijeli Brijeg neighbourhood of the city, although Clinic for infectious diseases, ...
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Celgene
3
Takeda
3
Janssen Research & Development, LLC
2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
2
SetPoint Medical Corporation
2
Aileron Therapeutics, Inc.
1
Altavant Sciences GmbH
1
Bosnalijek D.D
1
CEL-SCI Corporation
1
Can-Fite BioPharma
1
Galapagos NV
1
Clinical Trials at University Clinical Hospital Mostar
During the past decade, University Clinical Hospital Mostar conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 7 clinical trials were completed, i.e. on
average, 46.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction Adenocarcinoma
2007-11-01
2010-12-01
Completed
135
Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity
2010-12-01
2020-12-04
Completed
928
A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures
2012-02-21
2019-08-22
Completed
605
Safety and Efficacy Vagal Nerve Stimulation in Patients With Rheumatoid Arthritis
2011-07-01
2014-05-01
Completed
18
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
2013-04-01
2015-12-01
Terminated
696
Effects of Oral Sildenafil on Mortality in Adults With PAH
2014-09-22
2021-02-26
Terminated
385
MabionCD20® Compared to MabThera® in Patients With Rheumatoid Arthritis
2013-05-01
2017-10-01
Completed
709
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "University Clinical Hospital Mostar" #1 sponsor was "Celgene" with 3 trials, followed by "Takeda" with 3 trials
sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 2 trials sponsored and "SetPoint Medical Corporation"
with 2 trials sponsored. Other sponsors include 6 different institutions and
companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University Clinical Hospital Mostar"
#1 collaborator was "Gilead Sciences" with 1 trials as a collaborator, "Orient Europharma Co., Ltd." with 1 trials as a collaborator and "Teva Branded Pharmaceutical Products R&D, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at University Clinical Hospital Mostar
According to Clinical.Site data, the most researched conditions in "University Clinical Hospital Mostar" are
"Rheumatoid Arthritis" (4 trials), "Crohn Disease" (3 trials), "Crohn's Disease" (3 trials), "Colitis, Ulcerative" (2 trials) and "Pulmonary Arterial Hypertension" (2 trials). Many other conditions were trialed in "University Clinical Hospital Mostar" in a lesser frequency.
Clinical Trials Intervention Types at University Clinical Hospital Mostar
Most popular intervention types in "University Clinical Hospital Mostar" are "Drug" (20 trials), "Biological" (2 trials), "Device" (2 trials), "Other" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Ozanimod" (3 trials), "Cyberonics VNS System" (2 trials), "Guselkumab" (2 trials) and "ALRN-6924" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University Clinical Hospital Mostar
The vast majority of trials in "University Clinical Hospital Mostar" are
22 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at University Clinical Hospital Mostar
Currently, there are NaN active trials in "University Clinical Hospital Mostar".
1 are not yet recruiting,
6 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in University Clinical Hospital Mostar,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in University Clinical Hospital Mostar, 2 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 16 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".